tiprankstipranks
Trending News
More News >
Siemens Healthineers AG (DE:SHL)
XETRA:SHL
Germany Market

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

Compare
104 Followers
See the Price Targets and Ratings of:

SHL Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
8 Buy
5 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€53.57
▲(29.40% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €53.57 with a high forecast of €61.30 and a low forecast of €45.00. The average price target represents a 29.40% change from the last price of €41.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"40":"€40","51":"€51","62":"€62","45.5":"€45.5","56.5":"€56.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":61.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€61.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.573076923076925,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€53.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€45.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[40,45.5,51,56.5,62],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.346,42.880923076923075,44.415846153846154,45.950769230769225,47.485692307692304,49.02061538461538,50.55553846153846,52.09046153846154,53.62538461538461,55.16030769230769,56.69523076923077,58.23015384615384,59.76507692307692,{"y":61.3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.346,42.286544378698224,43.227088757396444,44.16763313609467,45.1081775147929,46.04872189349112,46.98926627218935,47.929810650887575,48.870355029585795,49.81089940828402,50.75144378698225,51.69198816568047,52.6325325443787,{"y":53.573076923076925,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.346,41.62707692307692,41.908153846153844,42.18923076923077,42.47030769230769,42.751384615384616,43.03246153846154,43.31353846153846,43.59461538461538,43.875692307692304,44.15676923076923,44.43784615384615,44.718923076923076,{"y":45,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.777,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.498,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.943,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.267,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.715,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.818,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.213,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.429,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.59,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.865,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.346,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€61.30Average Price Target€53.57Lowest Price Target€45.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DBS
€52
Buy
25.60%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
RBC Capital Analyst forecast on DE:SHL
RBC Capital
RBC Capital
€55
Buy
32.85%
Upside
Reiterated
02/20/26
Siemens Healthineers AG (SEMHF) Gets a Buy from RBC Capital
Citi
€60€59
Buy
42.51%
Upside
Reiterated
02/10/26
Siemens Healthineers price target lowered to EUR 59 from EUR 60 at CitiSiemens Healthineers price target lowered to EUR 59 from EUR 60 at Citi
Bernstein
€52.9€52.15
Buy
25.97%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)
Deutsche Bank  Analyst forecast on DE:SHL
Deutsche Bank
Deutsche Bank
€46
Hold
11.11%
Upside
Reiterated
02/06/26
Siemens Healthineers AG (SEMHF) Receives a Hold from Deutsche Bank
Goldman Sachs Analyst forecast on DE:SHL
Goldman Sachs
Goldman Sachs
€54
Hold
30.43%
Upside
Reiterated
02/05/26
Goldman Sachs Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)
Barclays
€61€59
Buy
42.51%
Upside
Reiterated
02/05/26
Barclays Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
UBS
€51
Hold
23.19%
Upside
Reiterated
02/05/26
UBS Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)
Berenberg Bank Analyst forecast on DE:SHL
Berenberg Bank
Berenberg Bank
€54
Buy
30.43%
Upside
Reiterated
02/05/26
Berenberg Bank Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Jefferies
€60
Buy
44.93%
Upside
Reiterated
02/05/26
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Boston Scientific (BSX)
J.P. Morgan Analyst forecast on DE:SHL
J.P. Morgan
J.P. Morgan
€61.3
Buy
48.07%
Upside
Reiterated
02/03/26
Analysts Conflicted on These Healthcare Names: Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Siemens Healthineers AG (Other OTC: SEMHF)
Morgan Stanley Analyst forecast on DE:SHL
Morgan Stanley
Morgan Stanley
€48€45
Hold
8.70%
Upside
Reiterated
12/15/25
Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€48
Hold
15.94%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Kepler Capital  Analyst forecast on DE:SHL
Kepler Capital
Kepler Capital
€59
Buy
42.51%
Upside
Reiterated
11/13/25
Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on DE:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
11/07/25
DZ BANK AG Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DBS
€52
Buy
25.60%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
RBC Capital Analyst forecast on DE:SHL
RBC Capital
RBC Capital
€55
Buy
32.85%
Upside
Reiterated
02/20/26
Siemens Healthineers AG (SEMHF) Gets a Buy from RBC Capital
Citi
€60€59
Buy
42.51%
Upside
Reiterated
02/10/26
Siemens Healthineers price target lowered to EUR 59 from EUR 60 at CitiSiemens Healthineers price target lowered to EUR 59 from EUR 60 at Citi
Bernstein
€52.9€52.15
Buy
25.97%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)
Deutsche Bank  Analyst forecast on DE:SHL
Deutsche Bank
Deutsche Bank
€46
Hold
11.11%
Upside
Reiterated
02/06/26
Siemens Healthineers AG (SEMHF) Receives a Hold from Deutsche Bank
Goldman Sachs Analyst forecast on DE:SHL
Goldman Sachs
Goldman Sachs
€54
Hold
30.43%
Upside
Reiterated
02/05/26
Goldman Sachs Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)
Barclays
€61€59
Buy
42.51%
Upside
Reiterated
02/05/26
Barclays Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
UBS
€51
Hold
23.19%
Upside
Reiterated
02/05/26
UBS Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)
Berenberg Bank Analyst forecast on DE:SHL
Berenberg Bank
Berenberg Bank
€54
Buy
30.43%
Upside
Reiterated
02/05/26
Berenberg Bank Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Jefferies
€60
Buy
44.93%
Upside
Reiterated
02/05/26
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Boston Scientific (BSX)
J.P. Morgan Analyst forecast on DE:SHL
J.P. Morgan
J.P. Morgan
€61.3
Buy
48.07%
Upside
Reiterated
02/03/26
Analysts Conflicted on These Healthcare Names: Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Siemens Healthineers AG (Other OTC: SEMHF)
Morgan Stanley Analyst forecast on DE:SHL
Morgan Stanley
Morgan Stanley
€48€45
Hold
8.70%
Upside
Reiterated
12/15/25
Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€48
Hold
15.94%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Kepler Capital  Analyst forecast on DE:SHL
Kepler Capital
Kepler Capital
€59
Buy
42.51%
Upside
Reiterated
11/13/25
Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on DE:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
11/07/25
DZ BANK AG Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months
xxx
Success Rate
11/23 ratings generated profit
48%
Average Return
-0.02%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 47.83% of your transactions generating a profit, with an average return of -0.02% per trade.
1 Year
Success Rate
13/32 ratings generated profit
41%
Average Return
+0.75%
a rating ―
Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 40.63% of your transactions generating a profit, with an average return of +0.75% per trade.
2 Years
xxx
Success Rate
25/56 ratings generated profit
45%
Average Return
-4.45%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.64% of your transactions generating a profit, with an average return of -4.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
1
1
1
0
Buy
14
25
23
23
21
Hold
2
3
6
8
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
29
30
32
30
In the current month, SHL has received 21 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 53.57.
Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.52 with a range of €0.49 to €0.56. The previous quarter’s EPS was €0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s earnings estimate for SHL is €0.52 with a range of €0.49 to €0.56. The previous quarter’s EPS was €0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €6.04B with a range of €5.66B to €7.13B. The previous quarter’s sales results were €5.40B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s sales forecast for SHL is €6.04B with a range of €5.66B to €7.13B. The previous quarter’s sales results were €5.40B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 53.57.
    What is DE:SHL’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers AG has 29.40% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers AG a Buy, Sell or Hold?
          Siemens Healthineers AG has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Siemens Healthineers AG’s share price target?
            The average share price target for Siemens Healthineers AG is 53.57. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €61.30 ,and the lowest forecast is €45.00. The average share price target represents 29.40% Increase from the current price of €41.4.
              What do analysts say about Siemens Healthineers AG?
              Siemens Healthineers AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers AG?
                To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.